Published in Saudi J Ophthalmol on July 01, 2013
Grading criteria for chronic ocular graft-versus-host disease: comparing the NIH eye score, Japanese dry eye score, and DEWS 2007 score. Sci Rep (2014) 0.79
Novel Scoring Criteria for the Evaluation of Ocular Graft-versus-Host Disease in a Preclinical Allogeneic Hematopoietic Stem Cell Transplantation Animal Model. Biol Blood Marrow Transplant (2016) 0.75
Corneal features in ocular graft-versus-host disease by in vivo confocal microscopy. Graefes Arch Clin Exp Ophthalmol (2017) 0.75
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant (2005) 19.83
The danger model: a renewed sense of self. Science (2002) 13.85
Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med (1980) 9.64
Graft-versus-host disease. Lancet (2009) 8.78
Chronic graft-versus-host disease. Biol Blood Marrow Transplant (2003) 5.36
Graft-versus-host disease. N Engl J Med (1991) 5.35
Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. Blood (2002) 3.56
Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology (2000) 2.74
Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis. J Clin Oncol (2001) 2.69
Molecules and mechanisms of the graft-versus-leukaemia effect. Nat Rev Cancer (2004) 2.65
Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med (1996) 2.63
Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transplant (2006) 2.44
The repeatability of clinical measurements of dry eye. Cornea (2004) 1.84
Recognizing and managing chronic graft-versus-host disease. Hematology Am Soc Hematol Educ Program (2008) 1.72
Acute graft-vs-host disease: pathobiology and management. Exp Hematol (2001) 1.70
Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant (2010) 1.69
Tarsorrhaphy: clinical experience from a cornea practice. Cornea (2001) 1.66
A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change. Biol Blood Marrow Transplant (2011) 1.54
The eye in bone marrow transplantation. VI. Retinal complications. Arch Ophthalmol (1994) 1.51
The eye in bone marrow transplantation. I. Clinical study. Arch Ophthalmol (1983) 1.51
Validation of measurement scales in ocular graft-versus-host disease. Ophthalmology (2011) 1.50
Ocular manifestations of graft-vs-host disease. Ophthalmology (1983) 1.50
Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease. Bone Marrow Transplant (2004) 1.37
Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management. Cancer (2004) 1.36
The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease. Arch Ophthalmol (1989) 1.34
Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren syndrome. Ophthalmology (1999) 1.33
Chronic graft versus host disease. Br J Haematol (2004) 1.33
Transplantation immunology: solid organ and bone marrow. J Allergy Clin Immunol (2010) 1.30
Graft-vs-host-disease-associated conjunctival chemosis and central serous chorioretinopathy after bone marrow transplant. Am J Ophthalmol (2002) 1.20
Ocular graft-versus-host disease after allogeneic stem cell transplantation. Cornea (2010) 1.16
Treatment of Sjögren's syndrome-associated dry eye an evidence-based review. Ophthalmology (2011) 1.07
Ocular findings after allogeneic hematopoietic stem cell transplantation. Ophthalmology (2009) 1.04
Ocular manifestations of graft-v-host disease. Arch Ophthalmol (1983) 1.04
Concise review: acute graft-versus-host disease: immunobiology, prevention, and treatment. Stem Cells Transl Med (2012) 1.02
Graft versus host disease: clinical evaluation, diagnosis and management. Graefes Arch Clin Exp Ophthalmol (2013) 1.00
Ocular graft-versus-host disease: a review. Surv Ophthalmol (2013) 1.00
Cataract formation after bone marrow transplantation. Ann Intern Med (1993) 1.00
Tailored approach to the treatment of vernal keratoconjunctivitis. Ophthalmology (2010) 0.99
Use of fluid-ventilated, gas-permeable scleral lens for management of severe keratoconjunctivitis sicca secondary to chronic graft-versus-host disease. Biol Blood Marrow Transplant (2007) 0.99
Topical azithromycin and oral doxycycline therapy of meibomian gland dysfunction: a comparative clinical and spectroscopic pilot study. Cornea (2013) 0.99
The use of topical cyclosporin A in ocular graft-versus-host-disease. Bone Marrow Transplant (1998) 0.98
Graft-vs.-host disease. Crit Rev Oral Biol Med (1997) 0.98
Comparison of autologous serum eye drops with different diluents. Curr Eye Res (2012) 0.98
Allogeneic serum eye drops for the treatment of dry eye patients with chronic graft-versus-host disease. J Ocul Pharmacol Ther (2012) 0.97
Diagnosis and clinical management of chronic graft-versus-host disease. Int J Hematol (2004) 0.95
The treatment of chronic graft-versus-host disease: consensus recommendations of experts from Germany, Austria, and Switzerland. Dtsch Arztebl Int (2011) 0.92
Phase II study of FK 506 for allogeneic bone marrow transplantation. Transplant Proc (1991) 0.90
Diagnosis and management of chronic graft-versus-host disease. Br J Haematol (2012) 0.90
Lacrimal gland involvement in graft-versus-host disease: a murine model. Invest Ophthalmol Vis Sci (2005) 0.86
Recurrent corneal perforation and acute calcareous corneal degeneration in chronic graft-versus-host disease. J Formos Med Assoc (2006) 0.86
Efficacy of hydroxypropyl cellulose ophthalmic inserts (LACRISERT) in subsets of patients with dry eye syndrome: findings from a patient registry. Cornea (2010) 0.86
The pathophysiology of chronic graft-versus-host disease: the unveiling of an enigma. Korean J Hematol (2011) 0.86
A randomized double-masked study of 0.05% cyclosporine ophthalmic emulsion in the treatment of meibomian gland dysfunction. Cornea (2012) 0.86
Clinical outcome of repeat penetrating keratoplasty. Cornea (2013) 0.84
Scleritis as the initial clinical manifestation of graft-versus-host disease after allogenic bone marrow transplantation. Am J Ophthalmol (2002) 0.83
Evaluation of the outcome of amniotic membrane transplantation for ocular surface reconstruction in symblepharon. Eye (Lond) (2004) 0.82
Bone marrow transplantation and cataract development. Arch Ophthalmol (1993) 0.82
Acute graft-versus-host disease: inflammation run amok? J Clin Invest (2001) 0.81
Long-term clinical course of dry eye in patients with chronic graft-versus-host disease referred for eye examination. Cornea (2011) 0.81
Effect of humidity variations in a controlled environment chamber on tear evaporation after dry eye therapy. Eye Contact Lens (2013) 0.81
Surgical management of lacrimal punctal cauterization in chronic GVHD-related dry eye with recurrent punctal plug extrusion. Bone Marrow Transplant (2012) 0.81
Progressive corneal vascularization caused by graft-versus-host disease. Cornea (2007) 0.80
Use of mini scleral contact lenses in moderate to severe dry eye. Cont Lens Anterior Eye (2012) 0.80
Slow-release artificial tear inserts in the treatment of dry eyes in patients with rheumatoid arthritis. Br J Ophthalmol (1989) 0.80
Indications and outcome of repeat penetrating keratoplasty in India. BMC Ophthalmol (2005) 0.79
Perforated corneal ulcer with subsequent endophthalmitis in a patient with graft-versus-host disease. Cornea (2007) 0.79
Preclinical evaluation of a novel episcleral cyclosporine implant for ocular graft-versus-host disease. Invest Ophthalmol Vis Sci (2005) 0.79
Ocular findings after bone marrow transplantation in a pediatric population. Ophthalmology (1999) 0.78
Laser photocoagulation for central serous retinopathy associated with graft-versus-host disease. Ocul Immunol Inflamm (2005) 0.78
Cataract surgery in allogeneic bone marrow transplant recipients with graft-versus-host disease(1). J Cataract Refract Surg (2002) 0.78
Successful treatment of acute ocular graft-versus-host disease with tacrolimus (FK506). Cornea (2002) 0.78
Multilayer amniotic membrane transplantation in severe ocular graft versus host disease. Eur J Ophthalmol (2001) 0.78
Acquisition of vernal and atopic keratoconjunctivitis after bone marrow transplantation. Am J Ophthalmol (2008) 0.78
Chronic graft-versus-host disease. Curr Opin Hematol (1998) 0.78
Systemic FK506 improved tear secretion in dry eye associated with chronic graft versus host disease. Br J Ophthalmol (2005) 0.78
Posterior segment complications of graft versus host disease after bone marrow transplantation. Br J Ophthalmol (2003) 0.77
Pemphigoid-like ocular lesions in patients with graft-versus-host disease following allogeneic bone marrow transplantation. Transplant Proc (2006) 0.76
[Graft-versus-host disease as the cause of symptoms mimicking Sjögren's syndrome]. Ann Acad Med Stetin (2006) 0.76
Infantile case of occlusive microvascular retinopathy after bone marrow transplantation. Jpn J Ophthalmol (2005) 0.75
Hematopoietic stem cell transplantation: a global perspective. JAMA (2010) 3.63
Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10. Hum Mol Genet (2007) 2.61
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Biol Blood Marrow Transplant (2011) 2.11
Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI. Blood (2013) 1.54
Enhancement of lytic activity of leukemic cells by CD8+ cytotoxic T lymphocytes generated against a WT1 peptide analogue. Leuk Lymphoma (2009) 1.47
New formula for calculating intraocular lens power after laser in situ keratomileusis. J Cataract Refract Surg (2004) 1.44
Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study. Haematologica (2013) 1.36
Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors. Blood (2010) 1.33
Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups. Haematologica (2012) 1.29
Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors. Haematologica (2010) 1.27
Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience. Blood (2013) 1.21
Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation. Blood (2014) 1.20
Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party. Blood (2012) 1.20
Influence of nucleated cell dose on overall survival of unrelated cord blood transplantation for patients with severe acquired aplastic anemia: a study by eurocord and the aplastic anemia working party of the European group for blood and marrow transplantation. Biol Blood Marrow Transplant (2010) 1.15
Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease. Am J Ophthalmol (2006) 1.14
Childhood blindness at a school for the blind in Riyadh, Saudi Arabia. Ophthalmic Epidemiol (2006) 1.10
A clinical approach to the diagnosis of retinal vasculitis. Int Ophthalmol (2009) 1.08
Causes of uveitis at The Eye Center in Saudi Arabia: a retrospective review. Ophthalmic Epidemiol (2002) 1.08
Ocular findings after allogeneic hematopoietic stem cell transplantation. Ophthalmology (2009) 1.04
Causes of uveitis at a referral center in Saudi Arabia. Ocul Immunol Inflamm (2009) 1.04
Corneal endothelial cytotoxicity of the Calotropis procera (ushaar) plant. Cornea (2008) 1.02
Complications of presumed ocular tuberculosis. Acta Ophthalmol (2010) 0.99
HLA-DRB1 among patients with Vogt-Koyanagi-Harada disease in Saudi Arabia. Mol Vis (2009) 0.94
Stem cell transplantation for chronic myeloid leukemia in children. Blood (2003) 0.94
Allogeneic hematopoietic stem cell transplantation in adolescent and adult patients with high-risk T cell acute lymphoblastic leukemia. Biol Blood Marrow Transplant (2012) 0.93
Intraocular lens power calculation following LASIK: determination of the new effective index of refraction. J Refract Surg (2006) 0.93
Biometric and molecular characterization of clinically diagnosed posterior microphthalmos. Am J Ophthalmol (2012) 0.92
The Wilms' tumor antigen is a novel target for human CD4+ regulatory T cells: implications for immunotherapy. Cancer Res (2008) 0.91
The impact of HLA unidirectional mismatches on the outcome of myeloablative hematopoietic stem cell transplantation with unrelated donors. Blood (2013) 0.90
Imatinib (STI-571)-induced exfoliative dermatitis in a Saudi patient with deck chair sign. Dermatology (2003) 0.88
Reversal of poliosis and vitiligo following Vogt-Koyanagi-Harada disease. Arch Ophthalmol (2012) 0.86
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Rev Bras Hematol Hemoter (2012) 0.86
Treatment of herpetic keratitis. Ophthalmology (2005) 0.86
Retinal vasculitis. Ocul Immunol Inflamm (2005) 0.85
Proteomic analysis of climatic keratopathy droplets. Invest Ophthalmol Vis Sci (2008) 0.85
Clinics of ocular tuberculosis. Ocul Immunol Inflamm (2015) 0.85
Outcome of aplastic anaemia in children. A study by the severe aplastic anaemia and paediatric disease working parties of the European group blood and bone marrow transplant. Br J Haematol (2015) 0.84
Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2008-2009: report on behalf of the Eastern Mediterranean Bone Marrow Transplantation (EMBMT) Group. Hematol Oncol Stem Cell Ther (2011) 0.84
Trisomy 4 as the sole karyotypic abnormality in a case of acute biphenotypic leukemia with T-lineage markers in minimally differentiated acute myelocytic leukemia. Cancer Genet Cytogenet (2004) 0.82
High efficacy and low toxicity of short-course oral valganciclovir as pre-emptive therapy for hematopoietic stem cell transplant cytomegalovirus infection. Hematol Oncol Stem Cell Ther (2010) 0.81
Identification of three novel plasminogen (PLG) gene mutations in a series of 23 patients with low PLG activity. Thromb Haemost (2010) 0.81
Fludarabine-based conditioning chemotherapy for allogeneic hematopoietic stem cell transplantation in acquired severe aplastic anemia. Biol Blood Marrow Transplant (2010) 0.81
Successful treatment of steroid-refractory autoimmune thrombocytopenia associated with Castleman disease with anti-CD-20 antibody (rituximab). Hematol Oncol Stem Cell Ther (2011) 0.81
Autologous bone marrow transplanation for extramedullary plasmacytoma presenting as adrenal incidentaloma. Ann Saudi Med (2009) 0.81
A study of KIR genes and HLA-C in Vogt-Koyanagi-Harada disease in Saudi Arabia. Mol Vis (2011) 0.80
Trends of hematopoietic stem cell transplantation in the Eastern Mediterranean region, 1984-2007. Biol Blood Marrow Transplant (2011) 0.80
Ongoing graft-versus-host disease is a risk factor for azoospermia after allogeneic hematopoietic stem cell transplantation: a survey of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Haematologica (2012) 0.79
Hematopoietic stem cell transplantation practice variation among centers in the Eastern Mediterranean Region (EMRO): Eastern Mediterranean Bone Marrow Transplantation (EMBMT) group survey. Hematol Oncol Stem Cell Ther (2013) 0.79
[Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation]. Rinsho Ketsueki (2014) 0.78
Pro-inflammatory cytokines and gelatinases in climatic droplet keratopathy. Invest Ophthalmol Vis Sci (2012) 0.78
The challenge of risk stratification in acute myeloid leukemia with normal karyotype. Hematol Oncol Stem Cell Ther (2010) 0.78
Acquisition of vernal and atopic keratoconjunctivitis after bone marrow transplantation. Am J Ophthalmol (2008) 0.78
Training practices of hematopoietic progenitor cell-apheresis and -cord blood collection staff: analysis of a survey by the Alliance for Harmonisation of Cellular Therapy Accreditation. Transfusion (2014) 0.78
Cancer prevention and control in the Eastern Mediterranean region: the need for a public health approach. Hematol Oncol Stem Cell Ther (2010) 0.78
Late onset corneal ectasia after LASIK surgery. Saudi J Ophthalmol (2011) 0.78
Cataract following posterior chamber phakic intraocular lens. J Refract Surg (2003) 0.77
The association of systemic disorders with Vogt-Koyanagi-Harada and sympathetic ophthalmia. Graefes Arch Clin Exp Ophthalmol (2011) 0.77
Differential diagnosis of retinal vasculitis. Middle East Afr J Ophthalmol (2009) 0.76
Is rasburicase needed for prevention of tumor lysis syndrome during treatment of less aggressive hematolymphoid malignancies? J Clin Oncol (2004) 0.76
Gastroesophageal reflux disease and its association with bronchiolitis obliterans syndrome in allogeneic hematopoietic stem cell transplant recipients. Exp Clin Transplant (2013) 0.76
Identification of a novel peptide derived from the M-phase phosphoprotein 11 (MPP11) leukemic antigen recognized by human CD8+ cytotoxic T lymphocytes. Hematol Oncol Stem Cell Ther (2010) 0.76
Outcome of corneal transplantation in a private institution in Saudi Arabia. Clin Ophthalmol (2013) 0.75
Birth order and transplantation outcome in HLA-identical sibling stem cell transplantation: an analysis on behalf of the Center for International Blood and Marrow Transplantation. Biol Blood Marrow Transplant (2013) 0.75
Reply: To PMID 22871625. Ann Saudi Med (2013) 0.75
The t(9;11) confers good prognosis in AML patients treated with stem cell transplantation as compared to non-t(9;11) and other adverse-risk abnormalities. Hematol Oncol Stem Cell Ther (2012) 0.75
Modification and implementation of NCCN guidelines on lymphomas in the Middle East and North Africa region. J Natl Compr Canc Netw (2010) 0.75
Uveitis in 2008: a festschrift for G. Richard O'Connor, MD. Am J Ophthalmol (2008) 0.75
Aqueous protein level and flare grading. Acta Ophthalmol (2014) 0.75
Diagnostic and therapeutic challenges. Bilateral occlusive retinal vasculitis. Retina (2012) 0.75
Infections following organ transplantation. Ophthalmology (2009) 0.75
Presumed reactivation of herpes zoster ophthalmicus following laser in situ keratomileusis. J Refract Surg (2002) 0.75
Erratum to "Filgrastim-Stimulated Bone Marrow Compared with Filgrastim-Mobilized Peripheral Blood in Myeloablative Sibling Allografting for Patients with Hematologic Malignancies: A Randomized Canadian Blood and Marrow Transplant Group Study" [Biol Blood Marrow Transplant 2016;22:1410-1415]. Biol Blood Marrow Transplant (2016) 0.75
MLL gene in maternal and infantile acute lymphoblastic leukemia and the effect of estrogen. Leuk Res (2011) 0.75
Leukemia relapse after allogeneic bone marrow transplantation: how does chronic graft-versus-host disease influence the pattern and onset of relapse? Exp Clin Transplant (2011) 0.75